Cargando…
同种异基因CAR-T细胞治疗复发/难治多发性骨髓瘤四例临床观察并文献复习
OBJECTIVE: To investigate the safety and efficacy of allogeneic CAR-T cells in the treatment of relapsed/refractory multiple myeloma (RRMM). METHODS: CAR-T cells were prepared from peripheral blood lymphocytes of HLA mismatch healthy donors. Median age was 55 (48–60). Allogeneic cells were derived f...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342886/ https://www.ncbi.nlm.nih.gov/pubmed/31495131 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.08.005 |